Therapy Induced Iron Deficiency in Children Treated With Eltrombopag for Immune Thrombocytopenia

American Journal of Hematology- United States

doi 10.1002/ajh.24705

Full Text

Abstract

Available in

Categories

Date

March 20, 2017

Authors

Michele P. Lambert

Janet L. Kwiatkowski

Publisher

Wiley

Related search

Eltrombopag-Based Combination Treatment for Immune Thrombocytopenia

Therapeutic Advances in Hematology

English

Tolerability and Efficacy of Eltrombopag in Chronic Immune Thrombocytopenia

Clinical and Applied Thrombosis/Hemostasis

English

Thrombopoietin Level Predicts Response to Treatment With Eltrombopag and Romiplostim in Immune Thrombocytopenia

American Journal of Hematology

English

Recurrent Coronary Thrombus in a Patient With Chronic Immune Thrombocytopenia With Treatment Using Eltrombopag

Case Reports in Cardiology

Cardiovascular Medicine

English

An Alternative Intermittent Eltrombopag Dosing Protocol for Treatment of Chronic Immune Thrombocytopenia

British Journal of Clinical Pharmacology

English

Rituximab for Children With Immune Thrombocytopenia: A Systematic Review

Multidisciplinary

English

Eltrombopag in Preparation for Surgery in Patients With Severe Myh9 ‐Related Thrombocytopenia

American Journal of Hematology

English

Methylprednisolone‐induced Immune Thrombocytopenia

American Journal of Hematology

English

Persistent Heparin-Induced Thrombocytopenia Treated With IVIg

Cardiovascular Medicine

Intensive Care Medicine

Respiratory Medicine

English